FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/25/2023
Back to search
Official data from USPTO
WUXI VACCINES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/29/2024
Trademark type
Combined
Nice classes
40, 42
Filing date
07/20/2021
Registration date
02/28/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/28/2023
Last transaction
04/29/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
CN
Examiner
FLETCHER, TRACY L
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized representation of a spiral and shaded circle next to four Chinese characters above the wording "WUXI VACCINES".
Holders and representatives
Holders
Shanghai Vaccines Co., Ltd.
Representatives
Eric Lamb Frost Brown Todd LLC
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom assembling of materials for others being custom manufacture of pharmaceuticalschemotherapy drugsantibiotic medicinesvaccines by pharmaceutical compounders; custom manufacture of pharmaceuticals medical preparation; customized production service being custom manufacturing of pharmaceuticals; customized production service being custom manufacturing of vaccines; medicinal materials processing being custom manufacture of pharmaceuticals; processing and treatment of chemical reagentscustom production of reagents for scientific or medical research use; processing of pharmaceutical materials for others being processing of medicinal plants and biological organisms; processing of biomedical materials for others being biomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; processing of chemical materials for vaccine production being custom manufacture of vaccines
Class 42
Development of new products for others; development of pharmaceutical preparations and medicines being research and development of new products for others; scientific research; medicine research services; research and development of new products; consulting services in the field of information technology development; biochemical research and analysis; biomedical research service; development of pharmaceutical preparations and medicines being research and development of new products for others; research and development of pharmaceuticals being research and development of new products for others
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/02/2023
FIMP
FINAL DISPOSITION PROCESSED
06/02/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/28/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/28/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/28/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/21/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/13/2022
PUBO
PUBLISHED FOR OPPOSITION
12/13/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/29/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/23/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/23/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/07/2022
ALIE
ASSIGNED TO LIE
11/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/30/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/30/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/30/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/30/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/30/2022
RFNT
REFUSAL PROCESSED BY IB
06/13/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/24/2022
RFRR
REFUSAL PROCESSED BY MPU
05/24/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/15/2022
CNRT
NON-FINAL ACTION WRITTEN
04/14/2022
DOCK
ASSIGNED TO EXAMINER
04/13/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/21/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/20/2022
Continuous trademark protection
Get notified about every new filing that threatens WUXI VACCINES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.